Search

Your search keyword '"Pharmaceutical industry -- International marketing"' showing total 1,033 results

Search Constraints

Start Over You searched for: Descriptor "Pharmaceutical industry -- International marketing" Remove constraint Descriptor: "Pharmaceutical industry -- International marketing"
1,033 results on '"Pharmaceutical industry -- International marketing"'

Search Results

1. Kenvue appoints Publicis Media as media agency for the APAC region

2. From Molecule to Market and Beyond: Uniphar Announces Extended Global Commercialization Platform

3. EVERSANA Transforms Pharmacovigilance & Drug Safety Industry with Oracle Collaboration, New Global Patient Support Model

4. Maharashtra pharma all set to expand global footprint

5. SIGA announces U.S. Government procurement order for Oral TPOXX

6. 1nhaler hires pharma industry leaders for key roles ahead of clinical trials

7. United Kingdom : 1nhaler hires pharma industry leaders for key roles ahead of clinical trials

8. Custom Antibody Market to Reach USD 901M by 2029 with 9.2% CAGR | MarketsandMarkets™

9. AstraZeneca is withdrawing its Oxford Covid vaccine worldwide; The jab has been voluntarily withdrawn from the European Union and will be withdrawn throughout the world

10. GET WELL SOON: Beauty brands and suppliers deliver holistic healing via superhero ingredients

11. Nanobiotix inks licensing, co-development & commercialization agreement with Janssen Pharma for potential first-in-class radioenhancer NBTXR3

12. Indoco buys 85% equity stake in US based FPP Holding

13. Amarna Therapeutics announces appointment of Aurelia Caparros as new Chief Business Officer

14. Amarna Therapeutics announces appointment of Aurelia Caparros as new Chief Business Officer

15. Global marketing industry survey to give insights into diversity within the GCC and worldwide

16. ATTORNEY GENERAL REYES ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC

17. MONTANA TO RECEIVE $1 MILLION FROM OPIOID SETTLEMENT WITH MULTINATIONAL MARKETING FIRM

18. ATTORNEY GENERAL LABRADOR ANNOUNCES $350 MILLION SETTLEMENT WITH MARKETING FIRM OVER ROLE IN OPIOID EPIDEMIC

19. ATTORNEY GENERAL TAYLOR ANNOUNCES SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS FOR ROLE IN OPIOID EPIDEMIC

20. ATTORNEY GENERAL RAOUL REACHES SETTLEMENT WITH MULTINATIONAL MARKETING FIRM FOR ROLE IN OPIOID EPIDEMIC

22. ATTORNEY GENERAL JOSH STEIN ANNOUNCES $350 MILLION OPIOID SETTLEMENT WITH MARKETING FIRM PUBLICIS

23. ATTORNEY GENERAL ROSENBLUM ANNOUNCES $350 MILLION NATIONAL SETTLEMENT WITH MARKETING GIANT PUBLICIS OVER ROLE IN OPIOID EPIDEMIC

24. ATTORNEY GENERAL MIYARES ANNOUNCES $350M SETTLEMENT WITH PUBLICIS FOR OPIOID MARKETING

25. AG JENNINGS ANNOUNCES $350 MILLION MULTISTATE SETTLEMENT WITH MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC

26. ATTORNEY GENERAL JOSH KAUL ANNOUNCES $350 MILLION SETTLEMENT WITH MARKETING FIRM OVER ITS ROLE IN OPIOID EPIDEMIC

27. ATTORNEY GENERAL TONG ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC

28. ATTORNEY GENERAL BONTA ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS HEALTH FOR ITS ROLE IN FUELING THE OPIOID CRISIS

29. AG CAMPBELL ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS HEALTH OVER ROLE IN OPIOID EPIDEMIC

30. ATTORNEY GENERAL FORMELLA ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC

31. ATTORNEY GENERAL CLARK ANNOUNCES VERMONT WILL RECEIVE $1 MILLION IN SETTLEMENT WITH MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC

32. ATTORNEY GENERAL PHIL WEISER ANNOUNCES $350 MILLION SETTLEMENT WITH MULTINATIONAL MARKETING FIRM PUBLICIS OVER ROLE IN OPIOID EPIDEMIC

33. Glenmark Life Sciences inks pact with Japanese innovator pharmaceutical company

34. Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa

35. Guardant Health and Hikma partner to offer cancer screening and genomic profiling tests in the ME and N. Africa

36. New History Findings Reported from New York University Shanghai (Marketing Modernity, Selling hazeline: a Comparative Study of Indian and Chinese Markets, 1908-1957)

37. AstraZeneca says Evusheld approved in Japan for COVID-19 prevention, treatment

38. BDA Bolsters Leadership Bench with Appointment of Divisional Vice President of Global Marketing and Creative Services

39. Unicoin Partners with FutureBrand for Iconic Rebranding and Launches a Stunning New Identity

40. Merck Appoints Axel Lober as Head of Global Communications and Stakeholder Engagement

41. NANOBIOTIX Announces Expiration of HSR Waiting Period Regarding the Agreement for Worldwide Co-Development & Commercialization of Potential First-in-Class Radioenhancer NBTXR3

42. PHARMANOVIA APPOINTS NEW GENERAL MANAGER FOR KOREA & JAPAN

43. Propeller

44. FourKites Named a Leader in the 2023 Gartner(R) Magic Quadrant(TM) for Third Consecutive Year

45. Qlik Announces 2023 Global Transformation Awards

46. Court of Justice of the European Union (General Court) Judgment: Pharmaceutical Works Polpharma v EMA (T-611|18)

47. Betagenon AB announces new CEO and new Chairman of the Board

48. Researcher from University of Crete Publishes Findings in Genetics (Transgenic Drosophila to Functionally Validate Fall Armyworm ABCC2 Mutations Conferring Bt Resistance)

49. By 2032, sales of intravenous immunoglobulin are expected to reach US$25,884 million, with 20% of that amount going toward treating immunodeficiency diseases. persistent market analysis

50. UK marketing authorisations for IOPIDINE(R) (apraclonidine) fully transferred to Essential Pharma as change in UK NICE guidelines for glaucoma treatment expected to lead to increase in patients' need for product

Catalog

Books, media, physical & digital resources